FREEDOM OF INFORMATION REQUESTS FEBRUARY 2013
FREEDOM OF INFORMATION REQUESTS APRIL 2013
| |
|Request |Response |
|FoI 636 – received 4 April 2013 |The Barnsley area formulary is available at the following link |
| |barnsleyformulary.nhs.uk. The formulary is updated on a |
|Do you have or adhere to a: |regular basis when changes are made by the Area Prescribing |
| |Committee, the Committee meet on a monthly basis. |
|Formulary | |
|Traffic Light List |I have also attached a copy of the traffic light list. |
| | |
|How often is this formulary updated? |The Barnsley formulary is a joint formulary across Barnsley |
| |CCG, BHNFT and the Barnsley Business Delivery Unit of SWYFT and|
|Please attach any relevant documents |all three organisations contribute to development of the |
| |formulary via the Area Prescribing Committee. |
|Do you have any plans to develop a formulary or any of the other documents |[pic] |
|detailed above? | |
| | |
| When are the formulary/ other documents due to be published? | |
| | |
| Will you utilise any other organisation's formularies in developing this | |
|formulary? | |
|FoI 637 – received 4 April 2013 |Barnsley CCG holds no recorded information in relation to this |
|Q1 Has the CCG had any discussions with the local pharmaceutical committee |enquiry. |
|regarding the provision of health services by community pharmacies in your | |
|area? |Any discussions or meetings which have been held with LPC |
| |members have been informal and not minuted by the CCG. |
|(Please note, services may include smoking cessation, minor ailments, weight | |
|management, EHC, vascular risk checks, Chlamydia screening, vaccinations etc) | |
| | |
|Q2 Where such a discussion has been held, please could you give me the | |
|following details: | |
|a)The date of the meeting | |
|b)A full list of the services discussed | |
|c)A full list of the attendees | |
|d)A copy of the minutes of the meetings | |
|FoI 638 – received 8 April 2013 |[pic] |
| | |
|Are you familiar with the new NICE guidance published in December 2012 | |
|regarding the approved access to advanced skin cancer treatments ipilimumab | |
|(Yervoy) (TA268) and vemurafenib (Zelboraf) (TA269)? | |
| | |
|Yes No | |
| | |
|If so, how is it being adopted locally? | |
| | |
|___________________________________________________________________________ | |
| | |
| | |
|Are you currently making ipilimumab and vemurafenib routinely available to | |
|those who need it following the publication of the guidance on 12th December | |
|2012? | |
| | |
|Yes No | |
| | |
|If not, why not? | |
| | |
|___________________________________________________________________________ | |
| | |
| | |
|If you answered “yes” to Question 2, did you make ipilimumab and vemurafenib | |
|routinely available to those who need it by 12th March 2013, the three month | |
|implementation deadline following the publication of NICE guidance? | |
| | |
|Yes No | |
| | |
|If not, what is the rationale for this? | |
| | |
|________________________________________________________________________ | |
| | |
| | |
|If you answered “yes” to Question 2, when exactly did you make ipilimumab and | |
|vemurafenib routinely available to those who need it? | |
| | |
|Before 1st January 2013 | |
|January 2013 | |
|February 2013 | |
|March 2013 | |
|April 2013 | |
| | |
|Have ipilimumab and vemurafenib now been incorporated into your local | |
|formulary? | |
| | |
|Yes No | |
| | |
|If not, why not? | |
|___________________________________________________________________________ | |
| | |
| | |
| Had ipilimumab and vemurafenib been incorporated into your local formulary by | |
|12th March 2013? | |
| | |
|Yes No | |
| | |
|If not, why not? | |
| | |
|________________________________________________________________________ | |
| | |
| | |
|Have relevant clinicians in your area been advised of the new NICE guidance on | |
|ipilimumab and vemurafenib? | |
| | |
|Yes No | |
| | |
|If not, why not? | |
| | |
|___________________________________________________________________________ | |
| | |
| | |
|How many applications for funding through Independent Funding Requests (IFRs) | |
|for ipilimumab (Yervoy) have you received since 12th March 2013? | |
|________________________________________________________________________ | |
| | |
| | |
|Of these applications, have any been refused? | |
| | |
|Yes No | |
| | |
|If so, how many and why? | |
| | |
|________________________________________________________________________ | |
| | |
|How many applications for funding through Independent Funding Requests (IFRs) | |
|for vemurafenib (Zelboraf) have you received since the publication of the NICE | |
|guidance (TA269) in December 2012 for the treatment of Melanoma (BRAF V600 | |
|mutation positive, unresectable metastatic)? | |
| | |
|________________________________________________________________________ | |
| | |
|Of these applications, have any been refused? | |
| | |
|Yes No | |
| | |
|If so, how many and why? | |
| | |
|___________________________________________________________________ | |
| | |
| | |
|Following Sir David Nicholson’s letter to NHS Chief Executives in August 2012 | |
|confirming the 1st April 2013 deadline for the introduction of the NHS | |
|Compliance Regime for Technology Appraisals, are you planning to make | |
|information about the availability of ipilimumab and vemurafenib available? | |
| | |
|Yes No | |
| | |
|If so, when are you planning to publish it? | |
| | |
|___________________________________________________________________________ | |
| | |
| | |
|Are you in the process of, or have you already carried out, a budgetary | |
|assessment relating to the impact of the positive guidance for the above | |
|treatments in your area? | |
| | |
|Yes No | |
| | |
|If so, do you have an estimated figure of the potential cost of the positive | |
|guidance? | |
| | |
|___________________________________________________________________________ | |
|FoI 639 – received 11 April 2013 |Kirsty Waknell, Communications and Engagement Manager, |
| |email:kirstywaknell@ |
|Could you please supply the names and email addresses of your staff operating | |
|under job titles such as Head of Marketing & Communications, Communications | |
|Manager or Officer, Account Manager - Communications etc., ideally anybody in | |
|the Communications unit. | |
|FoI 640 – received 12 April 2013 |There is only one commissioning team for the Continuing |
| |Healthcare Team in Barnsley which is:- |
|I would like the contact details for each of the 5 continuing healthcare | |
|commissioning teams within the Barnsley area. |Barnsley Clinical Commissioning Group |
| |c/o Hillder House |
| |49-51 Gawber Road |
| |Barnsley |
| |South Yorkshire |
| |S75 2PY |
| |Telephone: 01226 433756 |
|FoI 641 – received 12 April 2013 |[pic] |
| | |
|Please can you email me an Organisation Chart for the finance and accountancy | |
|function at the CCG. | |
|FoI 642 – received 16 April 2013 |[pic] |
| | |
|Q1 - Please detail all new measures your CCG has put in place for 2013/14 to | |
|limit GP referrals for any procedures deemed non-urgent or “low-clinical | |
|priority”. Please explain the rationale for making each of these changes. | |
|Q2 - Please state how much money the CCG estimates the measures outlined in the| |
|response to Q1 will save in 2013/14. | |
|Q3 - Please detail any specific changes the CCG has made for 2013/14 to the | |
|criteria for referring patients for any of the following procedures or | |
|treatments: | |
|Knee surgery/replacements | |
|Hip impingement/replacements/resurfacing | |
|Cataract surgery | |
|Tonsillectomies | |
|Bariatric surgery | |
|In vitro fertilisation (IVF) | |
|Open MRI scans | |
|Carpal tunnel syndrome | |
|Dupuytren’s contracture | |
|FoI 643 – received 19 April 2013 |[pic] |
|1) Please could you provide me with a copy of the current diabetes guidelines | |
|(as of 12 April 2013) that are being utilised by the CCG | |
|2) Where there is a current Local Enhanced Service (LES) for diabetes for the | |
|CCG, please can you provide a copy. | |
|3) Please can you provide a copy or link to the current formulary being | |
|utilised by the CCG (as of 12 April 2013) | |
|4) Please can you provide details of any prescribing targets or incentive | |
|schemes specific to diabetes or diabetes products for the year 2013 -2014 | |
|5) Please could you provide a copy or link to the commissioning plan for the | |
|CCG for year 2013 – 2014 | |
|If this address is not the appropriate address for a FOI enquiry - please | |
|could you acknowledge and forward to the appropriate contact. | |
|FoI 644 – received 23 April 2013 |Q1. West and South Yorkshire and Bassetlaw CSU |
|Please advise which commissioning support unit (if any) you are receiving | |
|commissioning support services from. Please detail all commissioning support |Q2. Business Intelligence |
|services you are receiving from the commissioning support unit, along with | Business Support |
|contract details for each service e.g. start date, end date, and value of | Procurement |
|contract. | Finance |
| | Corporate Governance |
| | Communications and Engagement |
| | Human Resources |
| | Organisational Health |
| | CHC / FNC |
| | Individual Funding Reviews |
| | Equality and Diversity |
| | |
| |Q3. The start date for the contracts is 1 April 2013 and the |
| |end date of 31 March 2014. Unfortunately the value of the |
| |contract is exempt under the Public authority’s own |
| |commercial activities. |
|FoI 645 – received 23 April 2013 |Barnsley CCG does not have a specific Commissioning Manager for|
|I’m currently updating our records and contact details and was hoping you could|Dermatology. |
|assist me with the name and email address of the current commissioning Manager | |
|of dermatology for the Barnsley CCG please. |All our Acute Contracts have Contract Managers assigned to |
| |them. Therefore if an issue arises with Dermatology at a |
| |specific hospital then this would be picked up by the |
| |appropriate Contract Manager. This is the way that we do our |
| |business and it is all part of a wider team the contact in the |
| |first instance would be Cheryl.Hobson@barnsleypct.nhs.uk. |
|FoI 646 – received 23 April 2013 |[pic] |
| | |
|[pic] | |
|FoI 647 – received 24 April 2013 |[pic] |
| | |
|[pic] | |
|FoI 648 – received 30 April 2013 |Dr Rob Farmer |
|I require the name, position and any contact details of the people who are |GP Clinical Lead and Elected Member of the CCG Governing Body |
|functioning as the Diabetes Clinical Lead and/or Long Term Conditions Lead for | |
|the Barnsley Clinical Commissioning Group that has recently been formed. |Robert.farmer@ |
|FoI 649 – received 30 April 2013 |Do you currently have a registered nurse in post on your |
|Do you currently have a registered nurse in post on your governing body as one |governing body as one of the two clinical members required by |
|of the two clinical members required by legislation? |legislation? Yes |
| | |
|If yes, when was the post holder appointed? Is it currently a substantive or an|If yes, when was the post holder appointed? Is it currently a |
|interim appointment? |substantive or an interim appointment? January 2013 full time |
| |substantive Chief Nurse |
|Have you appointed any other nurses or someone with a nursing background to | |
|your executive team, for example as a director of nursing, chief nurse or other|Have you appointed any other nurses or someone with a nursing |
|role? |background to your executive team, for example as a director of|
| |nursing, chief nurse or other role? As above full time |
| |substantive Chief Nurse |
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- freedom of speech bill of rights
- freedom of speech
- freedom of speech controversial issues
- freedom of speech definition
- freedom of speech legal definition
- freedom of expression
- freedom of speech law
- define freedom of speech
- freedom of rights act
- facts on freedom of speech
- laws against freedom of speech
- freedom of religion in school